Bright Minds Biosciences (DRUG) Return on Equity [ROE] (2021 - 2026)
Bright Minds Biosciences' Return on Equity [ROE] was 1.85% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.93 percentage points from 10.78% a year earlier and down 4.83 percentage points from the prior quarter.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Equity [ROE] at Bright Minds Biosciences came in at -27.88%, up 18.08 percentage points from FY2024.
- Return on Equity [ROE] has now increased for three consecutive fiscal years, with a five-year change of +96.02 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Equity [ROE] was -45.96% in FY2024 (+37.19 pp), -83.15% in FY2023 (+99301791.86 pp), -99301875.00% in FY2022 (-13171189.52 pp) and -86130685.48% in FY2021 (-86130561.58 pp).
- Quarterly Return on Equity [ROE] has moved between -185531861.87% (fiscal Q3 2023) and 10.78% (fiscal Q3 2025) over five years.
- Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +62.35 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q3 2024 (a gain of 185531720.33 percentage points); the worst was fiscal Q3 2026 (a drop of 8.93 percentage points).
- Per Business Quant data, DRUG's Return on Equity [ROE] in the three fiscal quarters before Q3 2026 was 6.68% (Q2 2026), -14.18% (Q1 2026) and -5.61% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | Bright Minds Biosciences | 375.76 Mn | 375.76 Mn | - | 1.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85% |
| Mar 31, 2026 | 6.68% |
| Dec 31, 2025 | -14.18% |
| Sep 30, 2025 | -5.61% |
| Jun 30, 2025 | 10.78% |
| Mar 31, 2025 | 1.23% |
| Dec 31, 2024 | -6.28% |
| Sep 30, 2024 | -63.33% |
| Jun 30, 2024 | -141.55% |
| Mar 31, 2024 | -170.99% |
| Dec 31, 2023 | -134.82% |
| Sep 30, 2023 | -62.73% |
| Jun 30, 2023 | -185,531,861.87% |
| Mar 31, 2023 | -156,143,739.42% |
| Dec 31, 2022 | -141,983,658.03% |
| Sep 30, 2021 | -13.40% |
API Access
Bright Minds Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();